Overview
A guanido-neuraminic acid that is used to inhibit neuraminidase.
Indication
For the prevention and treatment of influenza A and B.
Associated Conditions
- Flu caused by Influenza
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2022/12/13 | Phase 2 | Recruiting | |||
2021/04/30 | Phase 2 | Completed | |||
2020/10/22 | Phase 2 | Recruiting | |||
2020/07/31 | Phase 2 | Recruiting | |||
2015/03/03 | Phase 1 | Completed | |||
2012/02/06 | Phase 3 | Completed | |||
2011/10/31 | N/A | Completed | |||
2011/10/25 | Phase 3 | Completed | |||
2011/07/11 | N/A | Completed | |||
2011/05/16 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Dispensing Solutions Inc. | 68258-3030 | RESPIRATORY (INHALATION) | 5 mg in 1 1 | 3/2/2010 | |
| GlaxoSmithKline LLC | 0173-0681 | RESPIRATORY (INHALATION) | 5 mg in 1 1 | 10/19/2021 | |
| Physicians Total Care, Inc. | 54868-4377 | RESPIRATORY (INHALATION) | 5 mg in 1 1 | 5/18/2011 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
Authorised | 4/26/2019 | ||
Authorised | 4/26/2019 |
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| RELENZA ROTADISK 5 mg/dose | SIN11199P | POWDER, METERED | 5 mg/dose | 10/21/1999 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Zanamivir Powder for Inhalation | 国药准字HJ20140462 | 化学药品 | 吸入粉雾剂 | 4/20/2022 | |
| Zanamivir Powder for Inhalation | 国药准字H20103037 | 化学药品 | 粉雾剂 | 1/31/2020 | |
| Zanamivir Powder for Inhalation | H20140463 | 化学药品 | 吸入粉雾剂 | 7/22/2019 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| RELENZA POWDER FOR ORAL INHALATION 5MG | N/A | N/A | N/A | 1/28/2000 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| RELENZA ROTADISKS zanamivir 5mg insufflation blister pack | 66962 | Medicine | A | 4/21/1999 |
Help Us Improve
Your feedback helps us provide better drug information and insights.